PD Dr. Ramona Erber

List of publications:

BibTeX-Download

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Institute of Pathology

Publications

(87)

Comparison of PD-L1 mRNA Expression Measured with the CheckPoint Typer® Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung Cancer (2017) Erber R, Stoehr R, Herlein S, Giedl C, Rieker R, Fuchs F, Ficker JH, et al. Journal article Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis (2017) Haderlein M, Scherl C, Semrau S, Lettmaier S, Hecht M, Erber R, Iro H, et al. Journal article Pancreatic panniculitis in a patient with pancreatic-type acinar cell carcinoma of the liver--case report and review of literature (2016) Zundler S, Erber R, Agaimy A, Hartmann A, Kiesewetter F, Strobel D, Neurath M, Wildner D Journal article Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial (2016) Gluz O, Liedtke C, Huober J, Peyro-Saint-Paul H, Kates RE, Kreipe HH, Hartmann A, et al. Journal article Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer (2015) Fischbach A, Rogler A, Erber R, Stoehr R, Poulsom R, Heidenreich A, Schneevoigt BS, et al. Journal article Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial (2015) Erber R, Gluz O, Brünner N, Kreipe HH, Pelz E, Kates R, Bartels A, et al. Journal article Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (2014) Nitz U, Gluz O, Huober J, Kreipe HH, Kates RE, Hartmann A, Erber R, et al. Journal article

‹ 1 ... 7 8 9 ›